MedTrace Logo

Dyadic-Based Diagnosis, Care, and Prevention for HIV Discordant Couples in Tanzania

NCT03098693 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 128

Last updated 2022-02-07

No results posted yet for this study

Summary

This is a prospective observational study of couples in Kisarawe, Tanzania who will be provided an intervention that offers: (1) HIV self-testing kits and pre-test counseling provided at the household, (2) linkage to a counseling and referral center for those who test positive, (3) facilitated enrollment to care and treatment for couples with confirmed HIV infection; and (4) access to pre-exposure prophylaxis for the negative partner in a HIV sero-discordant couple. We will identify HIV sero-discordant couples through the HIV self-testing component, and through identifying discordant couples at the local HIV clinic. HIV sero-discordant couples (N=64 couples) will be administered a baseline, 6- ,12-, and 18-month survey, and the investigators will collect ongoing clinical data from each clinic visit. Biometric data (fingerprint) will be collected at enrollment, and all encounters with the counseling and referral center, and HIV treatment center, to allow linking of utilization of services with survey data.

Conditions

Interventions

BEHAVIORAL

HIV Self-Testing

Access to home-based HIV self-testing kits for stable couples.

BEHAVIORAL

Immediate Access to ART for HIV infected couple members

Immediate access to ART for HIV infected couple members (per current Tanzanian standard of care).

BEHAVIORAL

Access to PrEP for HIV uninfected couple members

Access to PrEP for HIV uninfected couple members.

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • Medical University of South Carolina

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-11-21
Primary Completion
2020-09-07
Completion
2020-09-07

Countries

  • Tanzania

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03098693 on ClinicalTrials.gov